Press Release – 17 September 2026
On 17 September 2026, Manipal Hospital Dhakuria in Kolkata announced that an 80‑year‑old female patient with recurrent heart failure caused by severe mitral regurgitation successfully underwent a MitraClip transcatheter edge‑to‑edge repair (TEER). The patient had a history of repeated hospitalisations for severe lung infections, bilateral pedal edema, worsening heart failure, and was on multiple medications with critical‑care support. Detailed evaluation confirmed severe mitral regurgitation with significant backflow of blood into the left atrium.
The MitraClip procedure, a minimally invasive catheter‑based repair that approximates the mitral valve leaflets, was performed by interventional cardiologists Dr Prakash Kumar Hazra and Dr Soumya Kanti Dutta. The intervention lasted approximately 30 minutes, avoiding the need for conventional open‑heart surgery, cardiopulmonary bypass, and extensive blood transfusions.
Dr Soumya Kanti Dutta explained that patients with comorbidities such as hypothyroidism, hypertension, obesity, diabetes, COPD, renal dysfunction, or those on multiple drugs often cannot tolerate mitral valve replacement under general anaesthesia, which requires significant blood transfusion and longer hospitalisation. He noted that the MitraClip offers an approachable, minimally invasive alternative for such high‑risk individuals.
Dr Prakash Kumar Hazra added that a multidisciplinary heart‑team discussion led to the decision to use the MitraClip, emphasizing that unlike valve replacement it is a repair technique that enhances longevity and reduces complications. He highlighted that the procedure eliminates the need for open‑heart surgery, reduces stroke risk, leaves no surgical scar, and enables quicker recovery. Because the device does not require lifelong anticoagulation (unless the patient has atrial fibrillation), anti‑platelet therapy can be discontinued within three months based on the patient’s clinical profile, thereby lowering bleeding risk. He also mentioned that the approach benefits patients with cancer, renal failure, or advanced diabetes by preventing recurrent hospitalisations.
Post‑procedure, the patient showed a significant reduction in mitral regurgitation, recovered well, and was discharged home within a few days. She remains stable, comfortable, and continues to recover at home.
About Manipal Hospitals
Manipal Hospitals is one of India’s leading integrated healthcare providers, operating a pan‑India network of 50 multispecialty hospitals with over 13,000 licensed beds across 14 states and union territories. It is the country’s largest multispecialty hospital network by bed capacity, supported by more than 11,000 doctors and 25,000 employees. The group serves over 7 million patients annually, including international patients, and holds NABH and AAHRPP accreditations, with several hospitals also accredited by NABL and recognised for excellence in nursing and emergency care.